Bahrain
Kuwait
Oman
Qatar
Saudi Arabia
UAE
Results 1 - 14 of about 14 for lipitor; (0.02 seconds)
Lipitor receives FDA approval for new indications
1 Apr '07 | Healthcare / News
... cholesterol-lowering medication to receive FDA approval for the reduction of the risk of hospitalisation for heart failure. This new approval expands the use of Lipitor to patients at high risk for cardiovascular events because of established heart disease such as prior heart attack, prior heart ...
Lipitor slashes stroke risk, say authors
1 Sep '06 | Healthcare / News
... Science, said: “This is important information for physicians because patients who have had a stroke are at much greater risk for suffering another one.“Patients taking Lipitor in this trial showed a significant reduction in stroke and coronary events. This is impressive when you consider that the ...
Middle East doctors welcome five new indications for cholesterol-lowering medication
28 Mar '07 | Press Releases
... certain types of heart surgery, hospitalization for heart failure, and chest pain in patients with heart disease. This new approval expands the use of Lipitor to patients at high risk for cardiovascular events because of established heart disease such as prior heart attack, prior heart surgery, or ...
A healthy return
22 Jul '07 | Healthcare / Features
... is already involved in almost every major segment of the therapeutic market. It produces the world's best-selling drug, cardiovascular treatment Lipitor, and perhaps the world's most high-profile drug, erectile dysfunction medication Viagra. Other big names include pain management drug Lyrica, and ...
A lack of chemistry
4 Sep '08 | Healthcare / Features
... senior manager of Pfizer's Middle East and Africa Group, now outweighs the commercial risk.Two of Pfizer's bestselling drugs, Lipitor and Viagra, are also among the most counterfeited. "That's the dilemma. I'm talking to you about counterfeit drugs with the purpose of educating physicians, but at ...
End of an era
4 Aug '08 | Healthcare / Features
... we have not seen a blockbuster for some time," says Hakim. Pfizer is set to lose the patent on its bestselling drug, the statin Lipitor, in 2011. "It's why generics are becoming a key strategy." From this perspective, the GCC's history of spurning generics in favour of branded drugs serves to make ...
The status of statins
19 Mar '08 | Healthcare / Interviews
... cancers among women taking lovastatin, simvastatin (Zocor), and fluvastatin (Lescol) - but no effect for pravastatin (Pravachol) or atorvastatin (Lipitor).Statins should be taken only when cholesterol remains high despite lifestyle changes. They may reduce gallstones. A 2007 report from the Nurses ...
Keeping the arteries clear
17 Jan '08 | Healthcare / Features
... , too.Studies are showing that for people in high-risk groups - those who have high blood pressure, or a history of heart problems - statins (Lipitor, Zocor, other brands) cut stroke risk, perhaps by stabilising atherosclerotic plaque instead of by lowering ‘bad' LDL cholesterol levels. The stroke ...
Pharmyard revolution
12 Aug '07 | Healthcare / Features
... tough at the top. Pfizer is already involved in almost every major segment of the therapeutic market. It produces hypercholesterolaemia treatment Lipitor (atorvastatin) which, with annual sales of $12bn, is far and away the world's bestselling drug, and perhaps the world's most high-profile drug, ...
Flaw in the ointment
1 Aug '07 | Healthcare / Features
... phenomenon," says Guy Willis, director of communications for the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). Viagra, Lipitor, Plavix - all popular and expensive drugs that are regularly prescribed - are prime targets for counterfeiters. While phony products may ...
In sickness & in health
17 Jul '07 | Healthcare / Interviews
... to patient groups in which a morbidity and mortality advantage had not been established. A Pfizer financial report on atorvastatin (Lipitor) states, "There continues to be an opportunity for further growth of the cholesterol-lowering market....Evolving treatment guidelines continue to encourage the ...
“Heart patients risk lives by stopping medication,” says study
15 Apr '07 | Press Releases
... followed completely. A retrospective analysis of a large managed care database recently showed that patients who took the cholesterol-lowering medicine Lipitor had a significant 14 percent reduction in the risk of cardiovascular events, including heart attacks and strokes, compared with patients ...
Advances in Cardiovascular care improve survival chances of Middle East’s heart patients
25 Mar '07 | Press Releases
... , fatal and non-fatal strokes, certain types of heart surgery, hospitalization for heart failure, and chest pain in patients with heart disease. Lipitor is the first cholesterol-lowering medication to receive FDA approval for the reduction of the risk of hospitalization for heart failure. "These ...
High marks for below-average cholesterol
14 Feb '06 | Healthcare / Features
... in other long-term studies of vegetarians.…and healthyThe advent of the powerful cholesterol-lowering drugs known as statins (Crestor, Lipitor, Zocor, and the like) has made it possible for virtually anyone to safely slash total and LDL cholesterol.Yet when these drugs first appeared in the late ...
Search Filters
Articles
- News (2)
- Features (7)
- Interviews (2)
Press Releases (3)
Industry
- Healthcare (11)
Magazine
Country
- Egypt (1)
- United Arab Emirates (11)
Mobile
